The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...

Every once in a while, a breakthrough doesn't just advance medicine—it changes the conversation entirely. SUNNYVALE, Calif., April 17, 2025 /PRNewswire/ -- EBR Systems, Inc. (ASX: EBR) has received ...

The major trials that established cardiac resynchronization therapy (CRT) as a treatment for heart failure (HF) with reduced ejection fraction (HFrEF) tended not to include patients who already had ...

BOSTON -- Early cardiac resynchronization therapy (CRT) benefited patients with moderately reduced ejection fraction (EF) and left bundle branch block (LBBB) but no indication for pacing, according to ...

Please provide your email address to receive an email when new articles are posted on . A leadless pacemaker can deliver cardiac resynchronization therapy to patients who cannot have conventional CRT ...

CHICAGO, Nov 14 (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that ...

BARCELONA, SPAIN—Cardiac resynchronization therapy (CRT) using an algorithm designed to minimize unnecessary right ventricular pacing is not superior to conventional CRT in patients with systolic ...

Electrophysiologists at the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin recently became the first in the U.S. to implant an FDA-approved leadless system for cardiac ...

The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT) showed a greater benefit with respect to mortality at 5 years among patients who received cardiac-resynchronization ...

BIOTRONIK’s BIO│WOMEN Study Enrolled 474 Patients Across Eight Countries in Europe and IsraelAddressing Critical Gaps as Women Often Remain Undiagnosed and Undertreated in Heart FailureThis ...